Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: results of an observational study

Introduction Although hormonal-therapy is the preferred first-line treatment for hormone-responsive, HER2 negative metastatic breast cancer, no data from clinical trials support the choice between hormonal-therapy and chemotherapy. Methods Patients were divided into two groups according to the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bighin, Claudia, Dozin, Beatrice, Poggio, Francesca, Ceppi, Marcello, Bruzzi, Paolo, D’Alonzo, Alessia, Levaggi, Alessia, Giraudi, Sara, Lambertini, Matteo, Miglietta, Loredana, Vaglica, Marina, Fontana, Vincenzo, Iacono, Giuseppina, Pronzato, Paolo, Mastro, Lucia Del
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546519/
https://www.ncbi.nlm.nih.gov/pubmed/28108743
http://dx.doi.org/10.18632/oncotarget.14735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546519/
https://www.ncbi.nlm.nih.gov/pubmed/28108743
http://dx.doi.org/10.18632/oncotarget.14735

Ejemplares similares